Scarica l'app Stockscreener
13.25
0.15%
0.02
Dopo l'orario di chiusura:
13.16
-0.09
-0.68%
Precedente Chiudi:
$13.23
Aprire:
$13.43
Volume 24 ore:
118.20K
Relative Volume:
1.55
Capitalizzazione di mercato:
$352.36M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.14%
1M Prestazione:
+2.08%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$12.80
$13.55
Intervallo di 1 settimana:
$12.34
$13.69
Portata 52W:
$11.45
$17.19
Carlsmed Inc Stock (CARL) Company Profile
Nome
Carlsmed Inc
Settore
Industria
Telefono
858-295-9290
Indirizzo
1800 ASTON AVENUE, CARLSBAD
Confronta CARL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.25 | 351.82M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Iniziato | BTIG Research | Buy |
| 2025-08-18 | Iniziato | BofA Securities | Buy |
| 2025-08-18 | Iniziato | Goldman | Buy |
| 2025-08-18 | Iniziato | Piper Sandler | Overweight |
| 2025-08-18 | Iniziato | Truist | Buy |
Carlsmed Inc Borsa (CARL) Ultime notizie
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance New Zealand
Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World
Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - Defense World
BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus
AI medtech firm Carlsmed prices $100.5M IPO - MSN
California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - Ortho Spine News
Carlsmed reports 61% revenue growth in Q4 2025 - Investing.com
More surgeons turn to AI-enabled spine surgery tech as Carlsmed grows - Stock Titan
Carlsmed, Inc.'s Lock-Up Period Set To End on January 19th (NASDAQ:CARL) - MarketBeat
Carlsmed, Inc.’s Lock-Up Period Set To End on January 19th (NASDAQ:CARL) - Defense World
Top Carlsmed (CARL) Competitors 2026 - MarketBeat
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - Ortho Spine News
Carlsmed’s personalized implants reduce spine surgery reoperations By Investing.com - Investing.com Nigeria
What is the current Price Target and Forecast for Carlsmed, Inc. (CARL) - Zacks Investment Research
Carlsmed Debuts AI-based Custom Implants for Cervical Spine Surgery - San Diego Business Journal
Critical Comparison: Longevity Health (NASDAQ:XAGE) vs. Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times
Inside the J.P. Morgan healthcare event Carlsmed is joining in 2026 - Stock Titan
BTIG Reiterates Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise By Investing.com - Investing.com South Africa
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise - Investing.com Nigeria
CARLSMED, INC. (CARL) Competitors - Meyka
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Ortho Spine News
Carlsmed launches personalized cervical fusion implant system By Investing.com - Investing.com Nigeria
Carlsmed Launches Aprevo Platform for Cervical Fusion Surgeries - marketscreener.com
Carlsmed launches personalized cervical fusion implant system - Investing.com
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - GlobeNewswire Inc.
Comparing Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. Stock (I82)Quote Deutsche Boerse AG - MarketScreener
Carlsmed, Inc.: Dividend historical data and projections - MarketScreener
Carlsmed, Inc.: Financial Data Forecasts Estimates and Expectations | I82 | US14280C1053 - MarketScreener
Carlsmed, Inc.: Revenue and Earnings Analysts Forecasts Revisions | I82 | US14280C1053 - MarketScreener
Carlsmed: Back To Where We Started - Seeking Alpha
Discontinued operations of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed, Inc. Cash Flow – FWB:I82 - TradingView
Basic earnings per share (basic EPS) of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed Reports Strong Q3 Growth and Raises Guidance - MSN
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Star TribuneCarlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference - FinancialContent
Carlsmed (NASDAQ:CARL) Raised to Hold at Wall Street Zen - MarketBeat
Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) Critical Contrast - Defense World
Truist Financial Reaffirms Buy Rating for Carlsmed (NASDAQ:CARL) - MarketBeat
Carlsmed Inc Azioni (CARL) Dati Finanziari
Non sono disponibili dati finanziari per Carlsmed Inc (CARL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
2.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):